Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:11:54 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



News for U:DGNOF from 2024-07-19 to 2025-07-18 - 29 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2025-07-16 09:00U:DGNOFNews ReleaseDIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC
2025-06-25 09:00U:DGNOFNews ReleaseDIAGNOS Welcomes Veteran Optometrist Dr. Barry A. Ginsberg to its Scientific Advisory Board for the United States
2025-06-10 11:47U:DGNOFNews ReleaseDIAGNOS Welcomes Founder of National Vision Associates, Ed Weiner, to its Advisory Board for the United States
2025-06-04 06:30U:DGNOFNews ReleaseDIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market
2025-05-23 12:03U:DGNOFNews ReleaseDIAGNOS Announces the Engagement of Allele Capital Partners
2025-05-20 15:15U:DGNOFNews ReleaseDIAGNOS Announces Amendment to Convertible Debentures
2025-04-16 06:30U:DGNOFNews ReleaseDIAGNOS announces major advances in Cybersecurity certification by the Cyber Defense Operations Center (COCD) for its CARA System application
2025-04-14 15:45U:DGNOFNews ReleaseDIAGNOS Provides Additional Information on Amendment to Convertible Debentures
2025-04-09 06:30U:DGNOFNews ReleaseDIAGNOS Provides Update on its Health Canada Medical Device Licence Application
2025-03-31 16:57U:DGNOFNews ReleaseDIAGNOS Announces Amendment to Convertible Debentures
2025-03-31 09:00U:DGNOFNews ReleaseDIAGNOS Opens First US Office in Florida
2025-03-12 09:15U:DGNOFNews ReleaseDIAGNOS is filing for the Saudi FDA Authorization of Its CARA SYSTEM, an AI Assisted Medical Device
2025-02-28 14:35U:DGNOFNews ReleaseDIAGNOS Announces Amendment to Convertible Debentures
2025-02-25 09:05U:DGNOFNews ReleaseDIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory Specialist
2025-02-24 10:38U:DGNOFNews ReleaseDIAGNOS to Present at Centurion One Capital 8th Annual Toronto Growth Conference
2025-02-14 15:30U:DGNOFNews ReleaseCorrection - Diagnos Announces Closing of Private Placement
2025-02-05 17:10U:DGNOFNews ReleaseDIAGNOS Announces Closing of Private Placement
2025-01-30 13:47U:DGNOFNews ReleaseDIAGNOS Announces Financial Contribution of $400,000 from the Government of Canada
2025-01-28 14:47U:DGNOFNews ReleaseDIAGNOS to Present at The Microcap Conference 2025
2025-01-13 15:30U:DGNOFNews ReleaseDIAGNOS Announces the Engagement of Promoter
2024-11-12 09:00U:DGNOFNews ReleaseDIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock Exchange
2024-10-25 15:45U:DGNOFNews ReleaseDIAGNOS Announces Closing of Private Placement
2024-10-17 15:45U:DGNOFNews ReleaseDIAGNOS Announces the Engagement of Market Maker Consultant
2024-10-03 15:30U:DGNOFNews ReleaseDIAGNOS Announces Grant of Stock Options
2024-09-26 12:09U:DGNOFNews ReleaseDIAGNOS Announces Voting Results of Meeting of Shareholders
2024-09-23 16:29U:DGNOFNews ReleaseDIAGNOS Announces Variation in One Insider Ownership
2024-09-20 15:54U:DGNOFNews ReleaseDIAGNOS Announces Closing of Private Placement
2024-08-22 15:45U:DGNOFNews ReleaseDIAGNOS Announces Date of Annual General and Special Meeting of Shareholders
2024-08-20 09:45U:DGNOFNews ReleaseDIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health Canada